Tos Mirko, Stangerup Sven-Eric, Cayé-Thomasen Per, Tos Tina, Thomsen Jens
Department of Otorhinolaryngology-Head and Neck Surgery, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
Arch Otolaryngol Head Neck Surg. 2004 Feb;130(2):216-20. doi: 10.1001/archotol.130.2.216.
To present the incidence of vestibular schwannoma (VS) in Denmark, compare the incidence with that of previous periods, and discuss the real incidence of VS.
DESIGN, SETTING, AND PATIENTS: Prospective registration of all diagnosed VS in Denmark, with a population of 5.1 to 5.2 million, during the 6 years from January 1996 through December 2001. Incidence in this period was compared with that of 3 previous periods (July 1976 through June 1983 [first period], July 1983 through June 1990 [second period], and July 1990 through December 1995 [third period]).
In the 1996-2001 period, 542 cases of VS were diagnosed, representing a mean incidence of 17.4 VS/1 million inhabitants per year. Of these, 227 tumors underwent operation, 14 underwent irradiation, and 301 were allocated to observation (wait-and-scan policy). One hundred sixty-six tumors were intrameatal. Size of extrameatal tumors was small in 104; medium in 194; large in 68; and giant (>40 mm) in 10. Compared with incidences of 7.8 VS/1 million inhabitants per year in the first, 9.4 VS/1 million inhabitants in the second, and 12.4 VS/1 million inhabitants in the third periods, the incidence for the 1996-2001 period represents an increase to 17.4 VS/1 million inhabitants per year. The mean incidence for the entire 25.5-year period was 11.5 VS/1 million inhabitants per year.
An estimate of a realistic mean incidence of VS depends on the observation period. Our 25.5-year registration of an entire population showed a mean incidence of 11.5 VS/1 million inhabitants per year. However, the latest period registered represents an incidence of 17.4 VS/1 million inhabitants per year, which, combined with a probable further increase of diagnosed tumors in forthcoming years, suggests a realistic incidence of approximately 13 VS/1 million inhabitants per year.
呈现丹麦前庭神经鞘瘤(VS)的发病率,将该发病率与之前各时期进行比较,并讨论VS的实际发病率。
设计、研究地点与患者:对1996年1月至2001年12月这6年间丹麦所有确诊的VS进行前瞻性登记,丹麦人口为510万至520万。将该时期的发病率与之前3个时期(1976年7月至1983年6月[第一个时期]、1983年7月至1990年6月[第二个时期]、1990年7月至1995年12月[第三个时期])的发病率进行比较。
在1996 - 2001年期间,共诊断出542例VS,平均发病率为每年每百万居民中有17.4例VS。其中,227例肿瘤接受了手术,14例接受了放疗,301例被分配至观察(等待与扫描策略)。166例肿瘤为内耳道内型。耳道外型肿瘤大小:小型104例;中型194例;大型68例;巨大型(>40 mm)10例。与第一个时期每年每百万居民中有7.8例VS、第二个时期每年每百万居民中有9.4例VS以及第三个时期每年每百万居民中有12.4例VS的发病率相比,1996 - 2001年期间的发病率增至每年每百万居民中有17.4例VS。整个25.5年期间的平均发病率为每年每百万居民中有11.5例VS。
对VS实际平均发病率的估计取决于观察期。我们对整个人口进行的25.5年登记显示,平均发病率为每年每百万居民中有11.5例VS。然而,最近登记的时期发病率为每年每百万居民中有17.4例VS,再加上未来几年确诊肿瘤可能会进一步增加,这表明实际发病率约为每年每百万居民中有13例VS。